RheaVita has been selected as the top pharmaceutical freeze-drying solution company in Europe for 2025!

ライフィクスアナリティカル

Award to RheaVita by Pharma Tech Outlook This award is backed by numerous recommendations from many readers of Pharma Tech Outlook and is a testament to the strong trust and high evaluation RheaVita has received from customers and industry stakeholders. As a result of a rigorous review by top executives, industry experts, and the editorial board, RheaVita has been selected as the "Top Pharmaceutical Freeze Drying Solution in Europe 2025."

Date and time
Capital
Entry fee

Related product information

RheaVita Corporation RheaLyo Mono System
Reduction of time/cost in process development and improvement of quality in freeze-drying of biopharmaceuticals.

【Other Features】 - Stable quality from preclinical trials to production during scale-up - Proven processes based on validated mechanical models and digital twin model-based design - Flexibility/production efficiency: short CIP/SIP times, flexible production volumes and capacities - Reduction of ecological footprint and operational costs (over 50%) *For more details, please refer to the PDF document or feel free to contact us.